BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1647942)

  • 1. [Beta 2-microglobulinuria in cytomegalovirus infections following kidney transplantation].
    Steinhoff J; Feddersen A; Wood WG; Bein G; Preuss R; Fricke L; Sack K
    Dtsch Med Wochenschr; 1991 Jun; 116(26):1008-12. PubMed ID: 1647942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L; Steinhoff J; Hartwig-Weber I; Bein G
    Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic problems in cytomegalovirus infection in patients with a transplanted kidney].
    Obujh NB; Martynova VN; Son'kina AA
    Ter Arkh; 1991; 63(6):79-81. PubMed ID: 1658959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of cytomegalovirus infection in recipients of renal transplantation].
    Fan J; Qian J; He Q; Ma WH; Chen JH; Zhou L; Cai T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):262-4. PubMed ID: 11986702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection.
    Van der Giessen M; van den Berg AP; van der Bij W; Postma S; van Son WJ; The TH
    Clin Exp Immunol; 1990 Apr; 80(1):56-61. PubMed ID: 2157567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-microglobulinuria as an early sign of cytomegalovirus infection following renal transplantation.
    Steinhoff J; Feddersen A; Wood WG; Hoyer J; Bein G; Wiedemann G; Fricke L; Sack K
    Transpl Int; 1992; 5 Suppl 1():S300-2. PubMed ID: 14621806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation.
    Schmidt CA; Oettle H; Peng R; Neuhaus P; Blumhardt G; Lohmann R; Wilborn F; Osthoff K; Oertel J; Timm H
    Transplantation; 1995 Apr; 59(8):1133-8. PubMed ID: 7732559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].
    Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H
    Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection in liver transplant recipients.
    Fan J; Ma WH; Qian J; Chen Z; Huang DS; Wang WL; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):30-2. PubMed ID: 14607618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
    Taherimahmoudi M; Ahmadi H; Baradaran N; Montaser-Kouhsari L; Salem S; Mehrsai A; Kalantar E; Jahani Y; Pourmand G
    Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selected markers of subclinical renal damage in men occupationally exposed to mercury vapours].
    Rutowski J; Moszczyński P
    Przegl Lek; 2006; 63 Suppl 7():65-73. PubMed ID: 17784548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial beta-2 microglobulin measurement as an auxilliary method in the early diagnosis of cytomegalovirus infection in renal transplant patients.
    Matos AC; Durão MS; Pacheco-Silva A
    Transplant Proc; 2004 May; 36(4):894-5. PubMed ID: 15194307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performance of the IgG avidity test in patients with cytomegalovirus disease].
    Lafarga B; Noguera FJ; Bolanos M; Pérez MC; Rodríguez H
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):190-5. PubMed ID: 9312277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.
    Bordils A; Plumed JS; Ramos D; Beneyto I; Mascarós V; Molina JM; Cordoba J; García J; Crúz JM
    Transplant Proc; 2005 Nov; 37(9):3756-9. PubMed ID: 16386529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus and beta 2 microglobulin in urine specimens. Reciprocal interference in their detection is responsible for artifactually high levels of urinary beta 2 microglobulin in infected transplant recipients.
    Grundy JE; McKeating JA; Sanderson AR; Griffiths PD
    Transplantation; 1988 Jun; 45(6):1075-9. PubMed ID: 2837846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection.
    Helanterä I; Teppo AM; Koskinen P; Törnroth T; Grönhagen-Riska C; Lautenschlager I
    Transpl Immunol; 2006 Jan; 15(3):217-21. PubMed ID: 16431289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.